Profile data is unavailable for this security.
About the company
Herborium Group, Inc. is a developer, licensor and marketer of herbal ingredient-based medicines and wellness products. The Company's flagship product, AcnEase is an herbal, oral treatment for patients with acne or rosacea. The Company serves clients worldwide. It is engaged in the development of a series of the artificial intelligence (AI)-based content products related to dermatological and beauty space. In addition to AcnEase, the Company has secured a pipeline of product candidates. The products include protein skin bar and adjunct cutting age skincare products based on stem cell technology. it is also ready for commercialization of new products line of natural sexual health and performance enhancing products for men and women. The Company owns all formulations for its proprietary products.
- Revenue in USD (TTM)340.33k
- Net income in USD-318.65k
- Incorporated1996
- Employees2.00
- LocationHerborium Group IncOne Bridge Plaza N Suite 275FORT LEE 07024United StatesUSA
- Phone+1 (201) 849-4431
- Fax+1 (866) 880-4817
- Websitehttps://www.herborium.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LadRx Corp | 0.00 | -2.77m | 584.21k | 2.00 | -- | -- | -- | -- | -5.59 | -5.59 | 0.00 | -1.89 | 0.00 | -- | -- | 0.00 | -113.62 | -58.97 | -653.73 | -78.44 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 106.96 | -- | -- | -- |
| Regen BioPharma Inc | 236.57k | -882.60k | 957.95k | 1.00 | -- | -- | -- | 4.05 | -0.1079 | -0.1079 | 0.0297 | -0.5897 | 1.04 | -- | 3.82 | 236,570.00 | -407.33 | -104.36 | -- | -- | -- | -- | -392.01 | -275.00 | -- | -1.36 | -- | -- | 0.4416 | 18.79 | -58.11 | -- | -- | -- |
| PaxMedica Inc | 0.00 | -17.66m | 1.09m | 6.00 | -- | -- | -- | -- | -7.54 | -7.54 | 0.00 | -0.2324 | 0.00 | -- | -- | 0.00 | -594.25 | -755.77 | -2,502.49 | -- | -- | -- | -- | -- | -- | -11,785.74 | -- | -- | -- | -- | -23.56 | -- | -- | -- |
| Herborium Group, Inc. | 340.33k | -318.65k | 1.09m | 2.00 | -- | -- | -- | 3.21 | -0.3492 | -0.3492 | 0.3672 | -1.16 | 2.32 | 3.89 | 25.94 | -- | -216.97 | -490.56 | -- | -- | 58.31 | 56.36 | -93.63 | -186.81 | 0.0331 | -39.14 | -- | -- | 19.45 | -18.15 | 120.44 | -- | -- | -- |
| Axim Biotechnologies Inc | 92.90k | -4.14m | 1.21m | 6.00 | -- | -- | -- | 13.00 | -0.0163 | -0.0163 | 0.0003 | -0.0324 | 0.0233 | -- | -- | 15,483.33 | -103.73 | -154.34 | -- | -390.73 | 16.94 | -- | -4,451.97 | -36,362.71 | -- | -3.14 | -- | -- | 345.05 | -27.38 | -29.10 | -- | -- | -- |
| Zyversa Therapeutics Inc | 0.00 | -21.86m | 1.29m | 7.00 | -- | 0.1211 | -- | -- | -100.63 | -100.63 | 0.00 | 10.32 | 0.00 | -- | -- | 0.00 | -84.85 | -- | -140.95 | -- | -- | -- | -- | -- | -- | -21,828.74 | 0.00 | -- | -- | -- | -340.15 | -- | -- | -- |
| Trevena Inc | 546.00k | -34.04m | 1.47m | 23.00 | -- | -- | -- | 2.69 | -47.76 | -47.76 | 0.7121 | -27.27 | 0.017 | -- | -- | 23,739.13 | -105.83 | -55.93 | -130.71 | -66.35 | -190.29 | -- | -6,233.70 | -3,134.41 | -- | -18.32 | 3.43 | -- | 847.61 | -11.43 | 24.93 | -- | -24.67 | -- |
| Panbela Therapeutics Inc | 0.00 | -28.56m | 1.54m | 7.00 | -- | -- | -- | -- | -84.64 | -84.64 | 0.00 | -2.18 | 0.00 | -- | -- | 0.00 | -197.23 | -215.89 | -3,522.07 | -476.38 | -- | -- | -- | -- | -- | -143.57 | -- | -- | -- | -- | 27.68 | -- | -- | -- |
| Kiromic Biopharma Inc | 0.00 | -26.21m | 1.55m | 35.00 | -- | -- | -- | -- | -19.73 | -19.73 | 0.00 | -3.35 | 0.00 | -- | -- | 0.00 | -167.49 | -161.04 | -- | -294.57 | -- | -- | -- | -- | -- | -7.22 | 1.74 | -- | -- | -- | 33.00 | -- | 8.52 | -- |
| Peak Bio Inc | 354.02k | -4.63m | 1.62m | -- | -- | -- | -- | 4.57 | -0.2066 | -0.2066 | 0.0135 | -0.9769 | 0.2192 | -- | -- | -- | -286.54 | -- | -- | -- | -- | -- | -1,307.11 | -- | -- | -4.85 | -- | -- | -39.46 | -- | 2.01 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Coston, McIsaac & Partners, Inc.as of 30 Sep 2024 | 1.00 | 0.00% |
